Post Operative RT for Limited Spine Metastases

Recruiting N/A Interventional Study
Spine Metastases
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
111 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To evaluate patients with limited spine metastases treated with total spondylectomy followed by conventional radiotherapy or debulking surgery followed by SBRT or conventional RT. The study primary endpoint is one year local control.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients who had pathologically proved solid cancer, with radiographic evident limited spine metastases indicative and feasible for spondylectomy or debulking surgery. 2. Patients with maximum two continuous level of spine metastases need for surgery are eligible. Patients wh…
Contacts

Wen Chi Yang

+886223123456

claireds23@ntuh.gov.tw

CONTACT